Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1Infections 1Hot Flashes 1Hematologic Neoplasms 1Fever 1

Interventions

Voriconazole 2Caspofungin 2telavancin 1monalizumab 1fludarabine phosphate 1fish oil triglycerides 1avdoralimab 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Therapeutics 1Tacrolimus 1Standard of Care 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Observation 1Methotrexate 1Melphalan 1Interferon-gamma 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Daptomycin 1Cyclophosphamide 1Clarithromycin 1Bevacizumab 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Infections × Daptomycin × Clear all
NCT00335478 2017-05-09

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
54 enrolled 4 charts

Fever, Infections, Neutropenia, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡